Genome Medical Services

Genome Medical Services

Genome Medical Services was founded in 2016 as a telehealth-based genetic counseling firm. The company is led by CEO Jill Davies, a genetic counselor herself, and operates out of San Francisco, United States. Its stated mission is to improve access to genetic guidance for individuals with rare conditions. The company's core offering includes telehealth genetic counseling, ordering of genetic tests, and clinical trial matching for patients. It partners with hospitals, health systems, life sciences organizations, and genetic testing labs to expand reach. Its team has delivered over 250,000 genetic counseling sessions, with a 96% patient satisfaction rating (per the firm, 2025). It is an in-network provider with most commercial health insurance plans, and works with most major genetic testing labs. Genome Medical does not disclose AUM or deployment, nor does it appear to manage external capital as an investment manager; it is a fee-for-service healthcare delivery entity. The company lists eight leadership team members and four clinical directors on its website. No additional offices or adjacent vehicles are publicly identified. Its structural differentiator is its clinician-led governance: many senior roles are held by practicing genetic counselors, not financial professionals. The company positions itself as an operating business focused on scaling rare-disease access, not managing pooled capital.